“Lebrikizumab-Treated Patients With Atopic Dermatitis Had No Increase in Treatment-Emergent Adverse Events of Facial, Head, and Neck Erythema Compared to Placebo”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s272. Accessed October 24, 2025. https://skin.dermsquared.com/skin/article/view/2383.